Hematopoiesis is a dynamic process resulting in continuous production of mature bloodforming cells from a relatively small population of primitive hematopoietic stem/progenitor cells through diverse proliferative and differentiative events [14] . Recent studies have revealed that the normal hematopoiesis requires associative interaction between hematopoietic cells and the cells of the hematopoietic microenvironment which are necessary for the critical maintenance of cell proliferation, maturation, and death [510] . Disruption of this fine balance between cell proliferation, cell survival and cell death plays a major role in development of several neoplastic diseases, particularly leukemia. Leukemia is a stem cell disease where normal stem cell function and behavior are lost due to transformation events [11, 12] . Leukemia development is a multistep process characterized by progressive cellular transformation of normal hematopoietic stem/progenitor cells into malignant leukemic clones. These leukemic clones could induce reversible changes in stromal function or composition which results in improved growth conditions for malignant cells (malignancyinduced microenvironment). The functionally abnormal malignant clones become an integral part of the stromal system, selectively stimulating neoplastic cells and inhibiting normal blood cell formation (malignant microenvironment) [13, 14] . Although malignant cells have an intrinsic growth and survival advantage, but they also remain dependent on some factors provided by the malignant microenvironment. Several recent studies have found the existence of a leukemic microenvironment [15] , however, the exact scenario of the alteration in stromal hematopoietic microenvironment and stromadependent surveillance of malignant cells still remains unclear.
In this study, we induced leukemia in mice by a potent carcinogenic agent NN爷 ethylnitrosourea (ENU). The initiation and progression of leukemia were ascertained by analyzing the blood hemogram profile and peripheral blood smears.
The alteration in stromal hematopoietic microenvironment in leukemia was assessed by longterm bone marrow cultures. Bone marrow adherent cell colony formation and colonyforming unitfibroblast (CFUF) assay were done to analyze the functional alteration of stromal hematopoietic components in leukemia if any. Further, the hematopoietic progenitor cell colony assays were used to analyze the stromaassociated changes in functional maturation or terminal differentiation of hematopoietic progenitor cells in leukemia. The expression of Sca1, CD146, vascular endothelial growth factor receptor 2 (VEGFR2), pSTAT3, pSTAT5, BclxL, and CD95 in leukemic bone marrow cells were detected. Our data collectively hinted the role of leukemic microenvironment in maintaining leukemic cell survivability.
A total of 120 inbred Swiss albino mice of either sex, aging 1014 days, were obtained from the Institutional animal house. Sixty mice were injected intraperitoneally with ENU (Sigma Co., USA) at a dose rate of 80100 mg/kg body weight. The mice were observed for 4 to 8 months. Peripheral blood hemogram was done to assess leukemic disease progression. Sixty mice received intraperitoneal injection of normal saline and were used as normal controls. During experiment, all mice were on normal diet and clean water ad libitum at 28益.
At 180 days after ENU induction, about 200300 滋 L of blood was collected from each mouse by tailvein puncture to evaluate certain hematological parameters. White blood cell (WBC) count, reticulocyte count, and percentage of blast cells from differential WBC count were determined using standard laboratory techniques. Peripheral blood smears were prepared and stained with standard Leishman staining.
At 180 days after ENU induction, the mice which showed progressive disease statuses were sacrificed to isolate the long bones (femurs and tibia). The long bones were cut in both ends by scissors and the redpulp region of the marrow was flushed out with RPMI1640 media (Sigma Co., USA) supplemented with 10% fetal bovine serum (FBS, GIBCO, BRL). Some portions of the isolated marrow were cut into small pieces (about 0.2 mm 3 ) and kept in RPMI1640 media containing 10% FBS for further culture protocol. The rest of the bone marrow was mixed well with repeated pipetting and passed through cell strainer to isolate single cells and washed in phosphate buffered saline (PBS) and finally transferred to RPMI1640 media (without FBS). RBCs were then depleted using RBCdepletion buffer (BD Biosciences, USA). Cells were kept in ice until use.
The small pieces (0.2 mm 3 ) of bone marrow from each mouse were cultured in triplicate in 75mm culture dish (Corning, USA) containing 4 mL of RPMI1640 supplemented with 30% FBS, 1% bovine serum albumin (BSA), 0.02% ( / ) 2mercaptoethanol, and 100 ng/mL recombinant mouse stem cell factor (SCF) (EBiosciences, USA), 50 ng/mL recombinant mouse interleukin3 (IL3) (BDBiosciences, USA), and 50 ng/mL recombinant mouse granulocytemacrophage colony stimulating factor (GMCSF) (BDBiosciences, USA). The cells were cultured at 37益 in an atmosphere of 5% CO 2 for 19 days. At different time course, the culture plates were monitored, and cellular growth pattern was observed and photographed under the inverted microscope.
For the bone marrow adherent cell colony assay, bone marrowderived cells were suspended in 4 mL of RPMI1640 medium supplemented with 30% FBS, 100 u/mL penicillin, 100 u/mL streptomycin, and 0.02% ( / ) 2mercaptoethanol at a concentration of 4 伊 10 6 cells/plate in 75 mm 伊 10 mm culture plates at 37益 and 5% CO 2 . Cells from each mouse were cultured in four plates. At every 72 h interval, the media was drained off, and fresh media supplemented with 30% FBS and 0.01% ( / ) 2mercaptoethanol was added for the maintenance of the culture. After 16 days of culture, the numbers of adherent colonies were scored using an inverted microscope.
www.cjcsysu.cn About 11.5 伊 10 6 bone marrowderived cells were plated into 75mm culture plate (Corning, USA) in triplicate in 琢 MEM with 30% FBS, Lglutamine, 100 u/mL streptomycin, 100 U/mL penicillin, and 0.01% ( / ) 2mercaptoethanol. At every 3rd day, the media was drained off and new media was added. For 2 weeks, the cultures were maintained at 37益 and 5% CO 2 . The resulting colonies were then scored using an inverted microscope.
Hematopoietic progenitor cells were assayed in methylcellulosebased semisolid media. The culture media consisted of 1.2% methylcellulose, 30% FBS, 1% BSA, 0.02% ( / ) 2mercaptoethanol, and 100 ng/mL recombinant mouse SCF, 50 ng/mL recombinant mouse IL3, and 50 ng/mL recombinant mouse GMCSF. RBCdepleted bone marrow cells were plated at a final concentration of 5 伊 10 5 cells/mL in triplicate and cultured at 37益 in 5% CO 2 . After 16 days of culture, colonies were scored using an inverted microscope.
RBCdepleted bone marrow cells were washed and fixed with 3% paraformaldehyde (PFA). To detect the membrane bound expression of Sca1, CD146, VEGFR2, and CD95, PFAfixed bone marrow cells from each groups were put in 4 tubes (1 伊 10 6 cells /tube) and treated with 2 滋 L of antimouse Sca1 PE, antimouse CD146 FITC, antimouse VEGFR2 PE and antimouse CD95 PEconjugated monoclonal antibodies, then incubated for 30 min in dark at 37益 . Finally, the cells were washed in PBS to wash off the excess fluorescence. Each tube was analyzed by a BDFACS Calibur (Becton Dickenson, San Jose, CA) according to the standard procedures and the data were analyzed using CellQuest pro software.
The bone marrow cells were initially incubated in RPMI1640 media containing 30% FBS with the combination of supportive microenvironmental factors like IL3 (50 ng/mL), GMCSF (50 ng/mL), and SCF (100 ng/mL), respectively, for 4 h at 37益 . To detect the intracellular expression of pSTAT3, pSTAT5, and BclxL, about 3 伊 10 6 stimulated bone marrow were mixed with 1.5% paraformaldehyde, incubated in the fixative for 10 min at room temperature, and pelleted and washed thrice with PBS, then permeabilized by resuspending with vigorous vortexing in 500 滋 L icecold methanol per 1 伊 10 6 cells and incubated at 4益 for 15 to 20 min. Cells were then washed twice in PBS containing 1% BSA and divided in 3 sorting tubes; each one contained 1 伊 10 6 cells in 100 滋 L media. Then 2 滋 L of rabbit antimouse pStat3, pStat5, and BclxL primary mAbs (Cell Signaling Technologies, USA) were added to the respective labeled tube and incubated for 30 min at room temperature followed by the addition of goat antirabbit secondary antibody conjugated with Alexa Fluor488 (Invitrogen, USA) to tube and incubated further for 30 min at room temperature. The cells were then washed with 15 volumes of staining media and pelleted. Finally, the pellets were resuspended in respective tubes containing 400 滋 L of staining media and analyzed by BD FACS Calibur (BectonDickenson, USA), using cell quest pro software.
All data are presented as mean ± standard deviation. Student爷s test was performed for intergroup comparison. A probability of < 0.01 was considered to be statistically significant.
Leukemia development was verified through peripheral blood hemogram profile and peripheral blood smear analysis. Of the 60 ENUtreated mice, 36 showed progressive leukemic disease status. To maintain parity in our study, we continued our experiments with 36 normal control mice.
Peripheral blood hemogram profiles showed that, compared with those in control mice, WBC count and the proportion of reticulocytes were significantly increased in The peripheral blood smears were stained with standard Leishman staining. A, the mice in control group received intraperitoneal injection of normal saline. The peripheral blood smear showed normal cellular distribution pattern with no hypergranular blast cells. B, the mice in leukemia group received intraperitoneal injection of N -N爷 ethylnitrosourea (ENU) at a dose rate of 80 -100 mg/kg body weight. The peripheral blood smear showed highly granular large cells, indicating they are immature, hypergranular blast cells. During the longterm culture, the bone marrow from control group showed no changes in the proportions and shapes of hematopoietic cells and stromal fibroblasts, whereas that from leukemic group showed an increase and elongation of stromal fibroblasts, resulting in a predominance and confluence of stromal fibroblasts ( Figure  2 ). Adherent bone marrow cell colonies were significantly increased in leukemic group than in control group during the culture ( < 0.01), whereas fibroblast colonyforming efficacy was significantly decreased in leukemia group than in control group ( < 0.001) ( Table 1) .
Leukemic marrow hematopoietic progenitors showed an overall decrease in colony formation than normal hematopoietic progenitors. Granulocyte colonyforming units (CFUG), granulocytes/macrophages colonyforming units (CFUGM), granulocyte/erythrocyte/monocyte/macrophage colony forming units (CFUGEMM), and erythroid burst forming units (BFUE) were all significantly decreased in leukemia group than in control group ( < 0.001) ( Table 1 ).
The granulocytic precursors/granulocytic population was significantly increased in leukemia group than in control group ( < 0.01), whereas the lymphocytic precursors/ lymphocytic population was significantly decreased in leukemic group than in control group ( < 0.01) (Figure 3 ).
Phenotypic characterization of Sca1 receptor expression on bone marrow cells indicated downregulated Sca1 bright population (more primitive progenitors), and Sca1 dim population (less primitive progenitors) in leukemia group as compared with control group ( < 0.01) (Figure 4 ). Phenotypic characterization of CD146 and VEGFR2 expression on bone marrow cells showed upregulated CD146 and VEGFR2 expression in leukemia group as compared with control group ( < 0.01) ( Figure 5 ). Fas antigen expression was also downregulated in leukemia group as compared with control group ( < 0.01) (Figure 6 ). A, at day 6 of culture, the bone marrow from mice in the control group showed a cumulative cell production and initiation of stromal matrix formation, with predominance of round hematopoietic cells over spindle鄄 shaped stromal fibroblasts; B, at day 6, the bone marrow from mice in the leukemic group showed extensive generation of large stromal fibroblasts and less hematopoietic cells; C, at day 9, the bone marrow from control group showed an obvious balance between the production of hematopoietic cells and stromal fibroblasts with significant predominance of stromal fibroblasts; D, at day 9, the bone marrow from leukemic group generated stromal fibroblasts which were abnormally elongated with almost absence of hematopoietic cells; E, at day 14, the bone marrow from control group showed interdependent co鄄 existence of hematopoietic cell colonies and stromal fibroblasts, which is essentially required for sustaining normal hematopoiesis; F, at day 14, the bone marrow from leukemic group showed that the highly elongated stromal fibroblasts reached a confluence and hematopoietic cells were kept aside; G, at day 19, the bone marrow from control group showed hematopoiesis with sufficient hematopoietic cell colonies upon the underlying adherent stromal microenvironment. The amount of torn鄄 ended stromal fibroblasts significantly decreased; H, at day 19, the bone marrow from leukemic group showed highly increased leukemic bone marrow cells. The confluence could be observed on different parts of the previously created stromal microenvironment, but the concentration of stromal fibroblasts was significantly reduced.
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The expression of pSTAT3, pStat5, and BclxL in bone marrow cells were increased in leukemia group than in control group (Figure 7) .
Hematopoiesis is a complex process of several Control Leukemia proliferative and differentiative signaling cascades responsible for the generation of healthy mature blood cells from a small population of hematopoietic stem/progenitor cells throughout the lifetime of an individual [16, 17] . The blood cell formation from single stem/progenitor cells requires continuous stimulation of various cytokines and growth factors secreted from its surrounding microenvironmental accessory cells or the niche components [1822] . Normal hematopoiesis is critically balanced by several cell proliferation, differentiation, and death signaling pathways. Alteration in one or more of these signaling pathways may ultimately shift the finely tuned equilibrium to other hypoproliferative or hyperproliferative disease condition. Under the condition of neoplastic progression such as leukemia, the normal hematopoietic cells can be transformed into leukemic cells. The resulting accumulative alterations in the leukemic cells shift the balance between cell proliferation and cell death towards the former, thus leading to a continuous increase of leukemic cells within the bone marrow microenvironment.
In this present study, we have used the mice model of leukemia developed by injecting ENU [23, 24] , a potent carcinogenic agent [2528] , to evaluate the changes in the characteristics of leukemia and deviation in the behavior of normal bone marrow microenvironment in leukemic disease progression. The disease progression was monitored by blood hemogram profile which demonstrated high increase in total granulocytic populations. The increased granulocytic population was confirmed by the flow cytometric analysis of leukemic bone marrow cells. The differential leukocyte count clearly showed significantly increased percentage of highly granular abnormal immature blast cells in the peripheral blood from mice in leukemic group.
We used the longterm bone marrow culture to assess the functional characterization of the stromal hematopoietic microenvironment and its role in aggravating the leukemic disease progression. A small piece of intact bone marrow (devoid of bone per se) can form the complex bone marrow microenvironment with appropriate architectural layout in invitro culture [29, 30] . We used the technique of Friedenstein .
[29] with some modifications to produce the entire meshwork of bone marrow stromal hematopoietic microenvironment from small pieces of intact bone marrow, to evaluate the changes in structure and function of the marrow stroma in leukemia. Our results clearly exhibited the defects in structure and function of the bone marrow stromal microenvironment during leukemogenesis. The bone marrow cells from control group could form the invivo hematopoietic stromal microenvironment in longterm culture condition. In normal bone marrow culture, the critical balance between adherent stromal matrix formation and hematopoietic cell generation was maintained during culture. In normal bone marrow cells, during the initial phase of the culture, the adherent stroma generation was rapid compared to hematopoietic cell development; however, the adherent stromal layer formation subsided with subsequent increased hematopoietic cell colony formation over the stromal adherent layer. In sharp contrast to the normal, the leukemic bone marrow cells showed almost complete shift of the equilibrium between adherent stromal layer formation and hematopoietic cell generation to the former. The leukemic bone marrow cells showed accelerated generation of abnormally elongated stromal cells in culture. The large stromal fibroblasts rapidly reached confluence in leukemia unlike the normal control. After the rapid formation of the complete meshwork of stromal hematopoietic [3134] . Several reports have stated the increased expression of the adhesion molecule CD146 on endothelial cells in different tissuespecific tumor progression. We observed increased expression of CD146 on leukemic bone marrow cells. The increased CD146 expression highly correlates with the increased adhesion property of the bone marrow endothelial cells which bind leukemic cells to promote leukemogenesis. We also observed increased VEGFR2 expression in leukemia. Because the leukemic blasts and other cellular components of stromal microenvironment like stromal fibroblasts and stromal endothelial cells account for increased VEGFR2 expression [35] , the increased endothelial cells in turn enhance the proliferation and support the maintenance of leukemic cells.
The complex interplay between leukemic cells and leukemic microenvironment alters several intertwined signaling processes involving cell growth, cell proliferation, and cell death that play vital roles in maintaining leukemic hematopoiesis [36] . The contribution of individual Stat proteins to normal cytokine signaling and development has been studied in various cell culture systems and in mice by gene disruption [37] . Some related roles and many unique non overlapping physiological roles of various members of Stat family have been identified. Beyond these various roles in normal cellular and physiological processes, the STAT proteins also participate in cellular transformation and oncogenesis [38] . Subsequent work showed that in several hematological malignancies, the STATs, particularly STAT3, are required to maintain the transformed phenotype of the cells [38] . STAT5 is activated in certain hematological malignancies, especially leukemia. Recent reports have stated the role of STAT5 in maintaining normal and leukemic hematopoiesis [39, 40] . Our results also showed high expression of both pSTAT3 and pSTAT5 in the leukemic bone marrow cells. Some reports stated that STAT3 activation is not essential for viability of normal and malignant cells [38] . Based on our data, we speculate that the expression of both pSTAT3 and pSTAT5 is essential for maintaining leukemic hematopoiesis and leukemic cell survivability in longterm culture. The evasion of programmed cell death (PCD) attracts much attention in cellular physiology that dictates the growth of malignant cells and is a hallmark of all cancers [41, 42] . Our results also demonstrated an antiapoptotic behavior of leukemic cells by upregulating the expression of antiapoptotic protein BclxL, a Bcl2 family protein which is known to be a key regulator of apoptosis [43, 44] . The subsequent downregulation of Fas antigen expression in leukemic bone marrow cells is well correlated with the increased antiapoptotic protein BclxL expression. Thus, our results hinted that the activated pSTAT3 and pSTAT5 expressed by the leukemic bone marrow cells played vital roles in maintaining leukemic hematopoiesis and leukemic cell survivability in long term by upregulating the antiapoptotic protein BclxL expression and blocking the Fas antigenmediated apoptosis pathway in leukemia.
In conclusion, interactions of leukemic cells with bone marrow microenvironmental stromal cells and soluble mediators are fundamental for leukemic hematopoiesis, leukemic cell survival, disease progression and resistance to treatment. Stromal leukemic microenvironment could promote leukemic hematopoiesis by altering several adhesion receptor expressions and signaling pathways involving cell differentiation and death. Although the understanding of these processes is deepened, we need to characterize the relative contribution and importance of the interactions and stromal cells involved in leukemogenesis. Exploring the behavior of leukemic stromal cells and malignant stromal components is a promising strategy for designing newly targeted therapies, ameliorating the disease progression, and limiting the resistance to conventional chemotherapy.
